{
    "Trade/Device Name(s)": [
        "ADVIA Centaur\u00ae Enhanced Estradiol (eE2) Master Curve Material"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics, Inc.",
    "510(k) Number": "K102904",
    "Predicate Device Reference 510(k) Number(s)": [
        "K062501"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "JJX"
    ],
    "Summary Letter Date": "November 5, 2010",
    "Summary Letter Received Date": "November 8, 2010",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality Control Material (Assayed and Unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine"
    ],
    "Analyte(s)": [
        "Enhanced Estradiol"
    ],
    "Specimen Type(s)": [
        "Human Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ADVIA Centaur\u00ae Enhanced Estradiol (eE2) assay"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Calibrator",
        "Reference Material"
    ],
    "Document Summary": "FDA 510(k) summary for ADVIA Centaur Enhanced Estradiol Master Curve Material for calibration verification in the ADVIA Centaur Enhanced Estradiol assay",
    "Indications for Use Summary": "For in vitro diagnostic use in the verification of calibration and reportable range in the ADVIA Centaur Enhanced Estradiol (eE2) assay",
    "fda_folder": "Clinical Chemistry"
}